Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Assessment of Peritoneal Membrane Arteriolar Structure in Conjunction with Traditional Cardiovascular System Evaluation in Chronic Kidney Disease (CKD) Stage 5 Patients.

Donderski R, Stróżecki P, Sulikowska B, Grajewska M, Trafny R, Bodnar M, Marszałek A, Stefańska A, Siódmiak J, Odrowąż-Sypniewska G, Manitius J.

Kidney Blood Press Res. 2018;43(3):1042-1052. doi: 10.1159/000490827. Epub 2018 Jun 25.

2.

Two succeeding fibroblastic lineages drive dermal development and the transition from regeneration to scarring.

Jiang D, Correa-Gallegos D, Christ S, Stefanska A, Liu J, Ramesh P, Rajendran V, De Santis MM, Wagner DE, Rinkevich Y.

Nat Cell Biol. 2018 Apr;20(4):422-431. doi: 10.1038/s41556-018-0073-8. Epub 2018 Mar 28.

PMID:
29593327
3.

Chronic kidney disease leads to hypoxia inducible factor-1alpha to hypoxia inducible factor-2alpha switch in the gastrocnemius muscle.

Flisinski M, Wisniewska-Chudy E, Brymora A, Stefanska A, Strozecki P, Manitius J.

J Physiol Pharmacol. 2017 Jun;68(3):419-425.

4.

Secreted products of Fasciola hepatica inhibit the induction of T cell responses that mediate allergy.

Finlay CM, Stefanska AM, Coleman MM, Jahns H, Cassidy JP, McLoughlin RM, Mills KHG.

Parasite Immunol. 2017 Oct;39(10). doi: 10.1111/pim.12460. Epub 2017 Sep 6.

PMID:
28815724
5.

Aldosterone antagonist therapy and its relationship with inflammation, fibrosis, thrombosis, mineral-bone disorder and cardiovascular complications in peritoneal dialysis (PD) patients.

Donderski R, Stróżecki P, Sulikowska B, Grajewska M, Miśkowiec I, Stefańska A, Siódmiak J, Odrowąż-Sypniewska G, Manitius J.

Int Urol Nephrol. 2017 Oct;49(10):1867-1873. doi: 10.1007/s11255-017-1655-2. Epub 2017 Jul 14.

6.

Extrapolation in the development of paediatric medicines: examples from approvals for biological treatments for paediatric chronic immune-mediated inflammatory diseases.

Stefanska AM, Distlerová D, Musaus J, Olski TM, Dunder K, Salmonson T, Mentzer D, Müller-Berghaus J, Hemmings R, Veselý R.

Arch Dis Child. 2017 Oct;102(10):952-957. doi: 10.1136/archdischild-2016-312259. Epub 2017 May 29. Review.

PMID:
28554892
7.

Localized hepatic lobular regeneration by central-vein-associated lineage-restricted progenitors.

Tsai JM, Koh PW, Stefanska A, Xing L, Walmsley GG, Poux N, Weissman IL, Rinkevich Y.

Proc Natl Acad Sci U S A. 2017 Apr 4;114(14):3654-3659. doi: 10.1073/pnas.1621361114. Epub 2017 Mar 22.

8.

Epidemiology of gastroenteropancreatic neuroendocrine neoplasms in Krakow and Krakow district in 2007-2011.

Trofimiuk-Müldner M, Lewkowicz E, Wysocka K, Pach D, Kiełtyka A, Stefańska A, Sowa-Staszczak A, Tomaszewska R, Hubalewska-Dydejczyk A.

Endokrynol Pol. 2017;68(1):42-46. doi: 10.5603/EP.2017.0006.

9.

Does combination of "cold" and "hot" somatostatin analogs prolong survival of patients with neuroendocrine neoplasms?

Sowa-Staszczak A, Stefanska A, Chrapczynski P, Trofimiuk-Müldner M, Szura M, Hubalewska-Dydejczyk A.

Endocr J. 2017 Feb 27;64(2):171-177. doi: 10.1507/endocrj.EJ16-0219. Epub 2016 Nov 17.

10.

Human kidney pericytes produce renin.

Stefanska A, Kenyon C, Christian HC, Buckley C, Shaw I, Mullins JJ, Péault B.

Kidney Int. 2016 Dec;90(6):1251-1261. doi: 10.1016/j.kint.2016.07.035. Epub 2016 Sep 24.

11.

99mTc Labeled Glucagon-Like Peptide-1-Analogue (99mTc-GLP1) Scintigraphy in the Management of Patients with Occult Insulinoma.

Sowa-Staszczak A, Trofimiuk-Müldner M, Stefańska A, Tomaszuk M, Buziak-Bereza M, Gilis-Januszewska A, Jabrocka-Hybel A, Głowa B, Małecki M, Bednarczuk T, Kamiński G, Kowalska A, Mikołajczak R, Janota B, Hubalewska-Dydejczyk A.

PLoS One. 2016 Aug 15;11(8):e0160714. doi: 10.1371/journal.pone.0160714. eCollection 2016.

12.

NEN - the role of somatostatin receptor scintigraphy in clinical setting.

Opalińska M, Hubalewska-Dydejczyk A, Sowa-Staszczak A, Stefańska A.

Nucl Med Rev Cent East Eur. 2016;19(2):118-25. doi: 10.5603/NMR.2016.0023. Review.

13.

IL-36α expression is elevated in ulcerative colitis and promotes colonic inflammation.

Russell SE, Horan RM, Stefanska AM, Carey A, Leon G, Aguilera M, Statovci D, Moran T, Fallon PG, Shanahan F, Brint EK, Melgar S, Hussey S, Walsh PT.

Mucosal Immunol. 2016 Sep;9(5):1193-204. doi: 10.1038/mi.2015.134. Epub 2016 Jan 27.

PMID:
26813344
14.

Cells of renin lineage express hypoxia inducible factor 2α following experimental ureteral obstruction.

Stefanska A, Eng D, Kaverina N, Pippin JW, Gross KW, Duffield JS, Shankland SJ.

BMC Nephrol. 2016 Jan 8;17:5. doi: 10.1186/s12882-015-0216-0.

15.

Helminth Products Protect against Autoimmunity via Innate Type 2 Cytokines IL-5 and IL-33, Which Promote Eosinophilia.

Finlay CM, Stefanska AM, Walsh KP, Kelly PJ, Boon L, Lavelle EC, Walsh PT, Mills KH.

J Immunol. 2016 Jan 15;196(2):703-14. doi: 10.4049/jimmunol.1501820. Epub 2015 Dec 16.

16.

Metabolic Syndrome and Menopause: Pathophysiology, Clinical and Diagnostic Significance.

Stefanska A, Bergmann K, Sypniewska G.

Adv Clin Chem. 2015;72:1-75. doi: 10.1016/bs.acc.2015.07.001. Epub 2015 Aug 21. Review.

PMID:
26471080
17.

Highly thermostable RadA protein from the archaeon Pyrococcus woesei enhances specificity of simplex and multiplex PCR assays.

Stefanska A, Gaffke L, Kaczorowska AK, Plotka M, Dabrowski S, Kaczorowski T.

J Appl Genet. 2016 May;57(2):239-49. doi: 10.1007/s13353-015-0314-5. Epub 2015 Sep 4.

PMID:
26337425
18.

Interstitial pericytes decrease in aged mouse kidneys.

Stefanska A, Eng D, Kaverina N, Duffield JS, Pippin JW, Rabinovitch P, Shankland SJ.

Aging (Albany NY). 2015 Jun;7(6):370-82.

19.

Changes in glomerular parietal epithelial cells in mouse kidneys with advanced age.

Roeder SS, Stefanska A, Eng DG, Kaverina N, Sunseri MW, McNicholas BA, Rabinovitch P, Engel FB, Daniel C, Amann K, Lichtnekert J, Pippin JW, Shankland SJ.

Am J Physiol Renal Physiol. 2015 Jul 15;309(2):F164-78. doi: 10.1152/ajprenal.00144.2015. Epub 2015 May 27.

20.

The fructose tolerance test in patients with chronic kidney disease and metabolic syndrome in comparison to healthy controls.

Donderski R, Miśkowiec-Wiśniewska I, Kretowicz M, Grajewska M, Manitius J, Kamińska A, Junik R, Siódmiak J, Stefańska A, Odrowąż-Sypniewska G, Pluta A, Lanaspa M, Johnson RJ.

BMC Nephrol. 2015 May 3;16:68. doi: 10.1186/s12882-015-0048-y.

21.

Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center.

Lewkowicz E, Trofimiuk-Müldner M, Wysocka K, Pach D, Kiełtyka A, Stefańska A, Sowa-Staszczak A, Tomaszewska R, Hubalewska-Dydejczyk A.

Pol Arch Med Wewn. 2015;125(5):337-46. Epub 2015 Apr 29.

22.

GLP-1 and exendin-4 for imaging endocrine pancreas. A review. Labelled glucagon-like peptide-1 analogues: past, present and future.

Hubalewska-Dydejczyk A, Sowa-Staszczak A, Tomaszuk M, Stefańska A.

Q J Nucl Med Mol Imaging. 2015 Jun;59(2):152-60. Epub 2015 Feb 26. Review.

23.

Association of FSH with metabolic syndrome in postmenopausal women: a comparison with CRP, adiponectin and leptin.

Stefanska A, Ponikowska I, Cwiklinska-Jurkowska M, Sypniewska G.

Biomark Med. 2014;8(7):921-30. doi: 10.2217/bmm.14.49.

PMID:
25307546
24.

Morphometric analysis of muscle fibre types in rat locomotor and postural skeletal muscles in different stages of chronic kidney disease.

Flisinski M, Brymora A, Elminowska-Wenda G, Bogucka J, Walasik K, Stefanska A, Strozecki P, Manitius J.

J Physiol Pharmacol. 2014 Aug;65(4):567-76.

25.
26.

Discovery and characterization of RecA protein of thermophilic bacterium Thermus thermophilus MAT72 phage Tt72 that increases specificity of a PCR-based DNA amplification.

Stefanska A, Kaczorowska AK, Plotka M, Fridjonsson OH, Hreggvidsson GO, Hjorleifsdottir S, Kristjansson JK, Dabrowski S, Kaczorowski T.

J Biotechnol. 2014 Jul 20;182-183:1-10. doi: 10.1016/j.jbiotec.2014.04.015. Epub 2014 Apr 28.

PMID:
24786823
27.

Impact of fructose diet and renal failure on the function of pancreatic islets.

Pokrywczynska M, Flisinski M, Jundzill A, Krzyzanowska S, Brymora A, Deptula A, Bodnar M, Kloskowski T, Stefanska A, Marszalek A, Manitius J, Drewa T.

Pancreas. 2014 Jul;43(5):801-8. doi: 10.1097/MPA.0000000000000111.

PMID:
24739489
28.

Confirming the causal role of advanced glycation end‑products in arterial stiffening. Authors' reply.

Stróżecki P, Kurowski R, Flisiński M, Stefańska A, Odrowąż-Sypniewska G, Manitius J.

Pol Arch Med Wewn. 2014;124(3):148-9. No abstract available.

29.

Novel highly thermostable endolysin from Thermus scotoductus MAT2119 bacteriophage Ph2119 with amino acid sequence similarity to eukaryotic peptidoglycan recognition proteins.

Plotka M, Kaczorowska AK, Stefanska A, Morzywolek A, Fridjonsson OH, Dunin-Horkawicz S, Kozlowski L, Hreggvidsson GO, Kristjansson JK, Dabrowski S, Bujnicki JM, Kaczorowski T.

Appl Environ Microbiol. 2014 Feb;80(3):886-95. doi: 10.1128/AEM.03074-13. Epub 2013 Nov 22.

30.

Advanced glycation end products and arterial stiffness in patients with diabetic nephropathy and patients with chronic kidney disease without diabetes.

Stróżecki P, Kurowski R, Flisiński M, Stefańska A, Odrowąż-Sypniewska G, Manitius J.

Pol Arch Med Wewn. 2013;123(11):609-16. Epub 2013 Nov 4.

31.

Toll IL-1R8/single Ig IL-1-related receptor regulates psoriasiform inflammation through direct inhibition of innate IL-17A expression by γδ T cells.

Russell SE, Stefanska AM, Kubica M, Horan RM, Mantovani A, Garlanda C, Fallon PG, Walsh PT.

J Immunol. 2013 Sep 15;191(6):3337-46. doi: 10.4049/jimmunol.1300828. Epub 2013 Aug 14.

32.

Retinoic acid expression associates with enhanced IL-22 production by γδ T cells and innate lymphoid cells and attenuation of intestinal inflammation.

Mielke LA, Jones SA, Raverdeau M, Higgs R, Stefanska A, Groom JR, Misiak A, Dungan LS, Sutton CE, Streubel G, Bracken AP, Mills KH.

J Exp Med. 2013 Jun 3;210(6):1117-24. doi: 10.1084/jem.20121588. Epub 2013 May 20.

33.

Blocking retinoic acid receptor-α enhances the efficacy of a dendritic cell vaccine against tumours by suppressing the induction of regulatory T cells.

Galvin KC, Dyck L, Marshall NA, Stefanska AM, Walsh KP, Moran B, Higgins SC, Dungan LS, Mills KH.

Cancer Immunol Immunother. 2013 Jul;62(7):1273-82. doi: 10.1007/s00262-013-1432-8. Epub 2013 May 9.

PMID:
23657628
34.

Glucagon-Like Peptide-1 Receptor Imaging with [Lys (40) (Ahx-HYNIC- (99 m) Tc/EDDA)NH 2 ]-Exendin-4 for the Diagnosis of Recurrence or Dissemination of Medullary Thyroid Cancer: A Preliminary Report.

Pach D, Sowa-Staszczak A, Jabrocka-Hybel A, Stefańska A, Tomaszuk M, Mikołajczak R, Janota B, Trofimiuk-Müldner M, Przybylik-Mazurek E, Hubalewska-Dydejczyk A.

Int J Endocrinol. 2013;2013:384508. doi: 10.1155/2013/384508. Epub 2013 Mar 31.

35.

Renal pericytes: multifunctional cells of the kidneys.

Stefańska A, Péault B, Mullins JJ.

Pflugers Arch. 2013 Jun;465(6):767-73. doi: 10.1007/s00424-013-1263-7. Epub 2013 Apr 16. Review. Erratum in: Pflugers Arch. 2013 Jun;465(6):919. Stefańska, A M [corrected to Stefańska, Ania]; Péault, B [corrected to Péault, Bruno]; Mullins, J J [corrected to Mullins, John J].

PMID:
23588377
36.

Assessment of real-world usage of lanreotide AUTOGEL 120 in Polish acromegalic patients - results from the prospective 12-month phase of Lanro-Study.

Orlewska E, Kos-Kudła B, Sowiński J, Sworczak K, Zgliczyński W, Andrysiak-Mamos E, Babińska A, Bałdys-Waligórska A, Bandurska-Stankiewicz E, Błaut K, Bolko P, Foltyn W, Jakubczyk D, Jawiarczyk-Przybyłowska A, Junik R, Juraniec O, Lewkowicz E, Lewczuk A, Matyjaszek-Matuszek B, Michałek K, Mucha S, Orłowska-Florek R, Peszel-Barlik M, Pynka S, Rosiek V, Ruchała M, Rutkowska J, Słynko-Krzyzostaniak J, Stefańska A, Strzelczyk J, Syrenicz A, Trofimiuk-Müldner M, Waligórska-Stachura J, Waśko R, Witek P, Zalewska-Rydzkowska D, Zdunowski P, Zemczak A.

Contemp Oncol (Pozn). 2013;17(5):460-5. doi: 10.5114/wo.2013.38805. Epub 2013 Nov 14.

37.

Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC- 99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma.

Sowa-Staszczak A, Pach D, Mikołajczak R, Mäcke H, Jabrocka-Hybel A, Stefańska A, Tomaszuk M, Janota B, Gilis-Januszewska A, Małecki M, Kamiński G, Kowalska A, Kulig J, Matyja A, Osuch C, Hubalewska-Dydejczyk A.

Eur J Nucl Med Mol Imaging. 2013 Apr;40(4):524-31. doi: 10.1007/s00259-012-2299-1. Epub 2012 Dec 7.

38.

Value of C-reactive protein as a risk factor for acute coronary syndrome: a comparison with apolipoprotein concentrations and lipid profile.

Krintus M, Kozinski M, Stefanska A, Sawicki M, Obonska K, Fabiszak T, Kubica J, Sypniewska G.

Mediators Inflamm. 2012;2012:419804. doi: 10.1155/2012/419804. Epub 2012 Oct 16.

39.

Decreased hypoxia-inducible factor-1α in gastrocnemius muscle in rats with chronic kidney disease.

Flisiński M, Brymora A, Bartłomiejczyk I, Wiśniewska E, Gołda R, Stefańska A, Pączek L, Manitius J.

Kidney Blood Press Res. 2012;35(6):608-18. doi: 10.1159/000339706. Epub 2012 Aug 29.

40.

Case report of a patient with initially inoperable well-differentiated midgut neuroendocrine tumor (WDNT)--PRRT and long-acting somatostatin analogs as the neoadjuvant therapy.

Sowa-Staszczak A, Pach D, Stefańska A, Szybiński P, Kulig J, Tomaszewska R, Chrzan R, Hubalewska-Dydejczyk A.

Nucl Med Rev Cent East Eur. 2012 Aug 26;15(2):137-9.

41.

Are RECIST criteria sufficient to assess response to therapy in neuroendocrine tumors?

Sowa-Staszczak A, Chrzan R, Pach D, Stefańska A, Tomaszuk M, Buziak-Bereza M, Kołodziej M, Przybylik-Mazurek E, Hubalewska-Dydejczyk A.

Clin Imaging. 2012 Jul-Aug;36(4):360-4. doi: 10.1016/j.clinimag.2011.11.005. Epub 2012 Jun 8.

PMID:
22726975
42.

Association of follicle-stimulating hormone and sex hormone binding globulin with the metabolic syndrome in postmenopausal women.

Stefanska A, Sypniewska G, Ponikowska I, Cwiklinska-Jurkowska M.

Clin Biochem. 2012 Jun;45(9):703-6. doi: 10.1016/j.clinbiochem.2012.03.011. Epub 2012 Mar 16.

PMID:
22449337
43.

Can treatment using radiolabelled somatostatin analogue increase the survival rate in patients with non-functioning neuroendocrine pancreatic tumours?

Sowa-Staszczak A, Pach D, Stefańska A, Tomaszuk M, Lenda-Tracz W, Mikołajczak R, Pawlak D, Chrzan R, Gilis-Januszewska A, Przybylik-Mazurek E, Hubalewska-Dydejczyk A.

Nucl Med Rev Cent East Eur. 2011;14(2):73-8.

44.

Efficacy and safety of 90Y-DOTATATE therapy in neuroendocrine tumours.

Sowa-Staszczak A, Pach D, Kunikowska J, Krolicki L, Stefanska A, Tomaszuk M, Buziak-Bereza M, Mikolajczak R, Matyja M, Gilis-Januszewska A, Jabrocka-Hybel A, Trofimiuk M, Hubalewska-Dydejczyk A.

Endokrynol Pol. 2011;62(5):392-400.

45.

Repeated cycles of peptide receptor radionuclide therapy (PRRT)--results and side-effects of the radioisotope 90Y-DOTA TATE, 177Lu-DOTA TATE or 90Y/177Lu-DOTA TATE therapy in patients with disseminated NET.

Pach D, Sowa-Staszczak A, Kunikowska J, Królicki L, Trofimiuk M, Stefańska A, Tomaszuk M, Głowa B, Mikołajczak R, Pawlak D, Jabrocka-Hybel A, Hubalewska-Dydejczyk AB.

Radiother Oncol. 2012 Jan;102(1):45-50. doi: 10.1016/j.radonc.2011.08.006. Epub 2011 Aug 30.

PMID:
21885142
46.

Heme oxygenase-1 inhibits myoblast differentiation by targeting myomirs.

Kozakowska M, Ciesla M, Stefanska A, Skrzypek K, Was H, Jazwa A, Grochot-Przeczek A, Kotlinowski J, Szymula A, Bartelik A, Mazan M, Yagensky O, Florczyk U, Lemke K, Zebzda A, Dyduch G, Nowak W, Szade K, Stepniewski J, Majka M, Derlacz R, Loboda A, Dulak J, Jozkowicz A.

Antioxid Redox Signal. 2012 Jan 15;16(2):113-27. doi: 10.1089/ars.2011.3964. Epub 2011 Oct 19.

47.

Regulation of chemerin chemoattractant and antibacterial activity by human cysteine cathepsins.

Kulig P, Kantyka T, Zabel BA, Banas M, Chyra A, Stefanska A, Tu H, Allen SJ, Handel TM, Kozik A, Potempa J, Butcher EC, Cichy J.

J Immunol. 2011 Aug 1;187(3):1403-10. doi: 10.4049/jimmunol.1002352. Epub 2011 Jun 29.

48.

Low-fructose diet lowers blood pressure and inflammation in patients with chronic kidney disease.

Brymora A, Flisiński M, Johnson RJ, Goszka G, Stefańska A, Manitius J.

Nephrol Dial Transplant. 2012 Feb;27(2):608-12. doi: 10.1093/ndt/gfr223. Epub 2011 May 25.

49.

Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs).

Sowa-Staszczak A, Pach D, Chrzan R, Trofimiuk M, Stefańska A, Tomaszuk M, Kołodziej M, Mikołajczak R, Pawlak D, Hubalewska-Dydejczyk A.

Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1669-74. doi: 10.1007/s00259-011-1835-8. Epub 2011 May 11.

50.

Comparison between C-reactive protein and adipocyte fatty acid-binding protein as a component of metabolic syndrome in middle-aged women.

Stefanska A, Sypniewska G, Blaszkiewicz B, Ponikowska I, Cwiklinska-Jurkowska M.

Clin Biochem. 2011 Mar;44(4):304-6. doi: 10.1016/j.clinbiochem.2010.12.002. Epub 2010 Dec 13.

PMID:
21159316

Supplemental Content

Loading ...
Support Center